Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 644 adverse event reports in the FDA FAERS database where TILDRAKIZUMAB was used for Psoriasis.

Most Reported Side Effects for TILDRAKIZUMAB

Side Effect Reports % Deaths Hosp.
Product dose omission issue 53 6.1% 7 12
Death 50 5.8% 50 7
Drug ineffective 50 5.8% 2 9
Psoriasis 37 4.3% 3 12
Urinary tract infection 36 4.1% 1 11
Pneumonia 33 3.8% 3 22
Off label use 27 3.1% 0 2
Condition aggravated 25 2.9% 0 5
Covid-19 25 2.9% 3 15
Inappropriate schedule of product administration 22 2.5% 3 6
Cerebrovascular accident 20 2.3% 0 15
Fatigue 17 2.0% 2 4
Myocardial infarction 17 2.0% 4 11
Cellulitis 16 1.8% 0 6
Pruritus 16 1.8% 1 6

Other Indications for TILDRAKIZUMAB

Product used for unknown indication (176) Psoriatic arthropathy (30) Hidradenitis (8) Lichen planus (6)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

TILDRAKIZUMAB Full Profile All Psoriasis Drugs TILDRAKIZUMAB Demographics TILDRAKIZUMAB Timeline